PFDN5 and Cognitive impairment: Since the overexpression of Pfdn5 restored the Tau-induced neurological abnormalities to the control levels without causing any detectable changes in synaptic morphology, cognitive impairment, or organismal health, we suggest that Pfdn5 could be a possible therapeutic target for Tauopathies.